← Open Payments lookup

ROBIN DANIEL: Open Payments

NPI 1437490059 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,648 in 92 payments from 10 companies in 2025. Trend: 2023 $939 · 2024 $1,329 · 2025 $1,648

Food & beverage: $1,537Education: $111
CompanyPaymentsAmount
Alkermes, Inc.20$388
Teva Pharmaceuticals USA, Inc.20$377
Otsuka America Pharmaceutical, Inc.19$319
Lundbeck LLC10$177
E.R. Squibb & Sons, L.L.C.9$155
Janssen Pharmaceuticals, Inc6$98
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$51
Axsome Therapeutics, Inc.3$51
Neurocrine BioSciences, Inc.1$19
Vanda Pharmaceuticals Inc.1$14

Products named: ARISTADA, ABILIFY ASIMTUFII, ABILIFY MAINTENA, UZEDY, COBENFY, AUSTEDO XR, INVEGA SUSTENNA, CAPLYTA.

Industry payments across NJ — which companies pay providers there.